Anthony Hunt, Director at REPLIGEN CORP (RGEN), sold 45,260 shares at $154.92 ($7.1M) on 2025-11-12, disclosed to the SEC on 2025-11-13.
Scheduled sale ($7.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.92 | 3,741 | $580K | 8.2% |
| 2 | $154.92 | 3,741 | $580K | 8.2% |
| 3 | $155.85 | 4,740 | $739K | 10.4% |
| 4 | $156.65 | 4,959 | $777K | 10.9% |
| 5 | $156.65 | 4,959 | $777K | 10.9% |
| 6 | $158.01 | 11,096 |
| $1.8M |
| 24.7% |
| 7 | $158.01 | 11,096 | $1.8M | 24.7% |
| 8 | $158.51 | 464 | $74K | 1.0% |
| 9 | $158.51 | 464 | $74K | 1.0% |
| Total | $156.99 avg | 45,260 | $7.1M | 100% |
| Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |
| RGEN | SELL | 2024-11-22 | $6.8M | — | Filing → |